• 四川大學(xué)華西醫(yī)院金卡醫(yī)院，四川成都 610041;

引用本文： 李燕,李雙慶. ACEI與ARB臨床聯(lián)合應(yīng)用防治糖尿病腎病. 華西醫(yī)學(xué), 2008, 23(1): 181-182. doi: 復(fù)制

1. Anderson S,Jung FF,Ingelfinger JR.Renal renin-angiotensin system in diabetes:functional,immunohistochemical,and molecular biological correlations[J].Am J Physiol,1993,265(4 Pt 2):F477-F486..
2. Kikkawa R,Kitamura E,Fujiwara Y,et al.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats[J].Ren Physiol,1986,9(3):187-92..
3. Touyz RM.Molecular and cellular mechanisms in vascular injury in hypertension:role of angiotensin Ⅱ[J].Curr Opin Nephrol Hypertens,2005,14(2):125-131..
4. Wolf G,Ziyadeh FN.The role of angiotensin Ⅱ in diabetic nephropathy:emphasis on nonhemodynamic mechanisms[J].Am J Kidney Dis,1997,29(1):153-163..
5. Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J].Kidney Int Suppl,2000,77:S93-S98..
6. Wolf G,Haberstroh U,Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type Ⅰ collagen in cultured murine mesangial cells[J].Am J Pathol,1992,140(1):95-107..
7. Huang XR,Chen WY,Truong LD,et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin Ⅱ-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol,2003,14(7):1738-1747;Comment in:1952-1954..
8. Mogensen CE,Neldam S,Tikkanen I,et al.Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension，microalbuminuria,and non-insulin dependent diabetes:the candesartan andlisinopril microalbuminuria(CALM)study.BMJ,2000,321:1440-1444..
9. Cao Z,Bonnet F,Candido R,et al.Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury[J].J Am Soc Nephrol,2002,13(7):1773-1787..
10. Komine N,Khang S,Wead LM,et al.Effect of combining an ACE inhibitor and an angiotensin Ⅱ receptor blocker on plasma and kidney tissue angiotensin Ⅱ levels[J].Am J Kidney Dis,2002,39(1):159-164..
11. Tütüncü NB,Gürlek A,Gedik O.Efficacy of ACE inhibitors and ATⅡ receptor blockers in patients with microalbuminuria:a prospective study[J].Acta Diabetol,2001，38:157-161..
12. Nakao N,Yoshimura A,Morita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme in Ahibitor in non-diabetic renal disease(COOPERATE):a randomised controlled trial[J].Lancet,2003,361:117-124..
13. Teo K,Yusuf S.Rationale,design,and baseline characteristics of 2 large,simple,randomized trials evaluating telmisartan,ramipril,andtheir combination in high-risk patients:The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials[J].Am Heart J,2004,148(1):52-61..
  1. 1. Anderson S,Jung FF,Ingelfinger JR.Renal renin-angiotensin system in diabetes:functional,immunohistochemical,and molecular biological correlations[J].Am J Physiol,1993,265(4 Pt 2):F477-F486..
  2. 2. Kikkawa R,Kitamura E,Fujiwara Y,et al.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats[J].Ren Physiol,1986,9(3):187-92..
  3. 3. Touyz RM.Molecular and cellular mechanisms in vascular injury in hypertension:role of angiotensin Ⅱ[J].Curr Opin Nephrol Hypertens,2005,14(2):125-131..
  4. 4. Wolf G,Ziyadeh FN.The role of angiotensin Ⅱ in diabetic nephropathy:emphasis on nonhemodynamic mechanisms[J].Am J Kidney Dis,1997,29(1):153-163..
  5. 5. Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J].Kidney Int Suppl,2000,77:S93-S98..
  6. 6. Wolf G,Haberstroh U,Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type Ⅰ collagen in cultured murine mesangial cells[J].Am J Pathol,1992,140(1):95-107..
  7. 7. Huang XR,Chen WY,Truong LD,et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin Ⅱ-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol,2003,14(7):1738-1747;Comment in:1952-1954..
  8. 8. Mogensen CE,Neldam S,Tikkanen I,et al.Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension，microalbuminuria,and non-insulin dependent diabetes:the candesartan andlisinopril microalbuminuria(CALM)study.BMJ,2000,321:1440-1444..
  9. 9. Cao Z,Bonnet F,Candido R,et al.Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury[J].J Am Soc Nephrol,2002,13(7):1773-1787..
  10. 10. Komine N,Khang S,Wead LM,et al.Effect of combining an ACE inhibitor and an angiotensin Ⅱ receptor blocker on plasma and kidney tissue angiotensin Ⅱ levels[J].Am J Kidney Dis,2002,39(1):159-164..
  11. 11. Tütüncü NB,Gürlek A,Gedik O.Efficacy of ACE inhibitors and ATⅡ receptor blockers in patients with microalbuminuria:a prospective study[J].Acta Diabetol,2001，38:157-161..
  12. 12. Nakao N,Yoshimura A,Morita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme in Ahibitor in non-diabetic renal disease(COOPERATE):a randomised controlled trial[J].Lancet,2003,361:117-124..
  13. 13. Teo K,Yusuf S.Rationale,design,and baseline characteristics of 2 large,simple,randomized trials evaluating telmisartan,ramipril,andtheir combination in high-risk patients:The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials[J].Am Heart J,2004,148(1):52-61..